Intuitive Announces Executive Leadership Changes - Seite 3
About Ion
Ion is Intuitive’s robotic-assisted platform for minimally invasive biopsy in the lung. The system features an ultra-thin, ultra-maneuverable catheter that allows navigation far into the peripheral
lung and provides the unprecedented stability necessary for precision in biopsy.
Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding executive leadership changes. These forward-looking statements include statements regarding our future
operational and financial performance, product development, market position and business strategy. These statements reflect the best judgment of the Company's management and involve a number of
risks and uncertainties that could cause actual results to differ materially from those suggested by the forward-looking statements. These forward-looking statements should, therefore, be
considered in light of the risk factors under the heading “Risk Factors” in our report on Form 10-K for the year ended December 31, 2020, as updated by the Company’s other filings with the
Securities and Exchange Commission. Statements using words such as “estimates,” “projects,” “believes,” “anticipates,” “plans,” “expects,” “intends,” “may,” “will,” “could,” “should,” “would,”
“targeted,” and similar words and expressions are intended to identify forward-looking statements. You are cautioned not to place undue reliance on these forward-looking statements, which speak
only as of the date of this press release. The Company undertakes no obligation to publicly update or release any revisions to these forward-looking statements, except as required by law.
For more information, please visit the company’s website at www.intuitive.com.
Lesen Sie auch
Contact
US/GLOBAL: Global Public Affairs
Intuitive Surgical
corp.comm@intusurg.com
+1-202-997-7373